Biotech Coverage Rankings

Ordered lists from our own accumulated coverage, story volume, average impact, entity mentions, and high-scored headlines. These ranks describe what we cover, not which companies or products are better. Every figure is a live aggregate; see our editorial methodology for how topics, mentions, and impact scores are derived.

Most-covered topic: Pharma (526 stories). Most-mentioned entity: FDA (87 stories).

Topics by Story Volume

All-time story count per topic across 811 tracked stories. Related: coverage statistics · compare topics.

  1. 1 Pharma
    526
  2. 2 Clinical Trials
    104
  3. 3 FDA Actions
    73
  4. 4 Funding
    60
  5. 5 Acquisitions
    21
  6. 6 Gene & Cell Therapy
    20
  7. 7 IPOs & Funding
    7

Topics by Average Impact

Average editorial impact score (0–10) among topics with at least one story. Volume and consequence are different signals, a quieter topic can outrank a busy one on impact.

  1. 1 Acquisitions 21 stories 6.7/10
  2. 2 FDA Actions 73 stories 6.6/10
  3. 3 Clinical Trials 104 stories 6.5/10
  4. 4 Gene & Cell Therapy 20 stories 6.2/10
  5. 5 Funding 60 stories 6/10
  6. 6 Pharma 526 stories 5.9/10
  7. 7 IPOs & Funding 7 stories 5.6/10

Most-Mentioned Entities

Top 25 by distinct story mentions above our minimum relevance threshold, who our coverage returns to most often, not a quality or recommendation ranking.

  1. 1 FDA organization
    87
  2. 2 Novo Nordisk company
    37
  3. 3 Eli Lilly company
    34
  4. 4 Donald Trump person
    21
  5. 5 Wall Street Zen company
    20
  6. 6 Weiss Ratings company
    19
  7. 7 Pfizer company
    18
  8. 8 U.S. Food and Drug Administration company
    17
  9. 9 GSK company
    16
  10. 10 Robert F. Kennedy Jr. person
    16
  11. 11 Trump Administration government
    14
  12. 12 China country
    12
  13. 13 World Health Organization organization
    12
  14. 14 Moderna company
    12
  15. 15 Bristol Myers Squibb company
    11
  16. 16 Novartis company
    10
  17. 17 Artificial Intelligence technology
    10
  18. 18 Johnson & Johnson company
    10
  19. 19 CDC organization
    9
  20. 20 AstraZeneca company
    9
  21. 21 HC Wainwright company
    9
  22. 22 Merck & Co. company
    9
  23. 23 India country
    8
  24. 24 Roche company
    8
  25. 25 Bundibugyo virus company
    7

Highest-Impact Stories

Fifteen stories with the highest editorial impact scores in this niche (ties broken by newer publish date). Impact weights regulatory, financial, and operational consequence, not headline volume.

  1. 1
    AstraZeneca and BMS in Talks for £300bn Biotech Consolidation Play

    Pharma ·

    9/10
  2. 2
    AstraZeneca, BMS Eye $400B Union to Build Cancer Powerhouse

    Acquisitions ·

    9/10
  3. 3
    Gene-Editing Death Rocks Biotech: Trillion-Virus Trial Under Investigation

    Clinical Trials ·

    9/10
  4. 4
    Merck’s oral PCSK9 inhibitor hits 59% LDL cut, leapfrogging injectable rivals

    FDA Actions ·

    9/10
  5. 5
    Cannabis Rescheduling Could Unlock $2.2B for Biotech & Pharma R&D, Challenger Says

    FDA Actions ·

    9/10
  6. 6
    $25M Extortion Bid Exposes Novo Nordisk’s Unreleased Drug Pipeline

    Pharma ·

    9/10
  7. 7
    $12B Bet on AGI Drug Design: Bezos’s Prometheus Targets Biotech Manufacturing

    Funding ·

    9/10
  8. 8
    Geopolitical Conflict in Middle East Threatens Global Pharma Supply Chains

    Pharma ·

    9/10
  9. 9
    Japan Grants World-First Approval for iPS Stem-Cell Parkinson's Therapy

    FDA Actions ·

    9/10
  10. 10
    B.C. Man Cured of Rare Disease in Landmark CRISPR Gene-Editing Success

    Gene & Cell Therapy ·

    9/10
  11. 11
    35 Flagged Efforts: Dual-Use AI in Gain-of-Function Research

    Funding ·

    8/10
  12. 12
    Anthropic's 3rd threat report details blocked AI bioweapons research

    Pharma ·

    8/10
  13. 13
    Boston Scientific Cyberattack Threatens Q3 Revenue by 600-700 bps

    Pharma ·

    8/10
  14. 14
    Rasonque Approved: KRAS Inhibitor Doubles Survival to 13.2 Months

    FDA Actions ·

    8/10
  15. 15
    Ebola's 47.6% CFR in DRC Intensifies Vaccine & Therapeutic Demand

    Pharma ·

    8/10

How These Rankings Are Computed

Every figure is a live SQL aggregate over Biotech Intelligence Brief's own story and entity tables for this niche, never a syndicated league table or an editor-typed Top-N. Topic ranks use full-population COUNT/AVG; entity ranks count distinct story mentions above the relevance threshold in our methodology. Found a discrepancy? Email hello@getbiobrief.com.

Cite This Page

"Biotech Coverage Rankings." Biotech Intelligence Brief. https://getbiobrief.com/rankings